Anti-ganglioside GM[2] monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes

Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes

Detection of thrombomodulin in human lung cancer cells

Human lung cancer antigen presentation by tumor-associated macrophages to CD4[+] lymphocytes from regional nodes

Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor

A newly established anti-interleukin-2 receptor β chain (p75) monoclonal antibody inhibits the induction of allo-specific cytotoxic lymphocytes in combination with anti-interleukin-2 receptor α chain (p55) monoclonal antibody

Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice

Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology

Enhancing effect of electric stimulation on cytotoxicity of anti-cancer agents against rat human glioma cells

A novel type of cell death of lymphocytes induced by a monoclonal antibody against cell surface antigens without participation of complement

Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin α6 subunit expression

In vitro targeting of CD8[+] T cells infiltrating into human head and neck squamous cell carcinoma using anti-CD3 × anti-c-erbB-2 bispecific antibody

Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by Human Urinary Bladder Cancer Cells

Augmentation by bispecific F(ab')[2] reactive with P-glyco-protein and CD3 of cytotoxicity of human effector cells on P-glycoprotein positive human renal cancer cells

Apoptosis induction in human breast cancer MRK-nu-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP)

Monoclonal antibodies against a human gastric cancer cell line with lung metastatic potential in nude mice define antigens with different expression between the primary and metastatic liver lesions